Loading...

IBD Competition Will Limit Pipeline Progress Despite Early Promise

Published
07 Aug 25
n/a
n/a
AnalystLowTarget's Fair Value
n/a
Loading
1Y
-36.5%
7D
6.3%

Author's Valuation

US$8.6783.1% overvalued intrinsic discount

AnalystLowTarget Fair Value